Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

CTLA-4 down-regulates the protective anticryptococcal cell-mediated immune response.

T McGaha1, J W Murphy

  • 1Department of Microbiology and Immunology, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma 73190, USA.

Infection and Immunity
|July 19, 2000
PubMed
Summary

Blocking CTLA-4 during immunization enhances cell-mediated immune responses against Cryptococcus neoformans. This blockade improves delayed-type hypersensitivity and reduces fungal load, offering potential for enhanced host defenses.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Design and implementation of the Americas Hernia Society Quality Collaborative (AHSQC): improving value in hernia care.

Hernia : the journal of hernias and abdominal wall surgery·2016
Same author

WAG-F8(m1Ycb) rats harboring a factor VIII gene mutation provide a new animal model for hemophilia A.

Journal of thrombosis and haemostasis : JTH·2010
Same author

Sigmoid colonic fistula secondary to Perfix-plug, left inguinal hernia repair.

Hernia : the journal of hernias and abdominal wall surgery·2006
Same author

Tolerability and anti-inflammatory effects of glucuronoxylomannan in collagen-induced arthritis.

Scandinavian journal of immunology·2004
Same author

Use of the prolene hernia system for inguinal hernia repair: retrospective, comparative time analysis versus other inguinal hernia repair systems.

The American surgeon·2001
Same author

Lack of skin fibrosis in tight skin (TSK) mice with targeted mutation in the interleukin-4R alpha and transforming growth factor-beta genes.

The Journal of investigative dermatology·2001

Area of Science:

  • Immunology
  • Microbiology
  • Infectious Diseases

Background:

  • Cell-mediated immunity (CMI) plays a dual role in Cryptococcus neoformans infections, with delayed-type hypersensitivity (DTH) responses being either protective or nonprotective.
  • The efficacy of CMI responses is influenced by the specific immunogens used and the resulting T-cell profiles.
  • Cytotoxic T lymphocyte antigen 4 (CTLA-4) is a key regulator of T-cell activation and immune responses.

Purpose of the Study:

  • To investigate the impact of blocking the interaction between CTLA-4 and its ligands (B7-1/CD80 and B7-2/CD86) on anticryptococcal DTH responses.
  • To determine if CTLA-4 blockade influences protection against Cryptococcus neoformans infection.
  • To assess the timing of CTLA-4 blockade in relation to immunization and its effect on immune response development and protection.

Related Experiment Videos

Main Methods:

  • Mice were immunized with either a protective immunogen (CneF in CFA) or a nonprotective immunogen (heat-killed cryptococcal cells, HKC).
  • CTLA-4 blockade was administered either at the time of immunization or after the immune response was established.
  • Anticryptococcal DTH reactivity, CMI response kinetics, fungal burden (CFU), and survival rates were assessed.

Main Results:

  • CTLA-4 blockade at the time of immunization enhanced anticryptococcal DTH reactivity regardless of the immunogen used.
  • Blocking CTLA-4 led to earlier development of CMI responses and reduced fungal loads in multiple organs in an infection model.
  • Long-term protection, indicated by increased survival, was observed only in mice treated with CTLA-4 blockade and immunized with the protective CneF-CFA, not with HKC.

Conclusions:

  • Blockade of CTLA-4 interactions with its ligands can enhance anticryptococcal DTH responses and CMI.
  • The timing of CTLA-4 blockade is critical; administration during immunization is effective, whereas post-induction blockade is not.
  • CTLA-4 blockade shows potential for augmenting host defenses against Cryptococcus neoformans, particularly when combined with appropriate immunogens.